Hennion & Walsh Asset Management, Inc. Pliant Therapeutics, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.1 Billion
- Q4 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 108,608 shares of PLRX stock, worth $1.19 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
108,608
Previous 91,974
18.09%
Holding current value
$1.19 Million
Previous $1.03 Million
38.7%
% of portfolio
0.07%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding PLRX
# of Institutions
169Shares Held
63.2MCall Options Held
245KPut Options Held
373K-
Deep Track Capital, LP Greenwich, CT5.97MShares$65.7 Million2.47% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$54.7 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.83MShares$53.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.53MShares$38.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA3.2MShares$35.2 Million2.34% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $536M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...